Skip to content

Lavender aromatherapy as an adjunctive therapy for pediatric drug-resistant epilepsy patients: a randomized-placebo controlled trial

Lavender aromatherapy as an adjunctive therapy for pediatric drug-resistant epilepsy patients: a randomized-placebo controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250130002
Enrollment
120
Registered
2025-01-30
Start date
2025-02-03
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pediatric drug-resistant epilepsy patients Epilepsy, drug-resistance, lavender

Interventions

Patients will be given lavender essential oil diluted with coconut oil (as a carrier) in a 1:10 ratio to ensure the concentration is appropriate for use in children. Apply the diluted lavender essenti
Experimental group (Lavender oil),Control group (Coconut oil)

Sponsors

Phramongkutklao hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: 1. Children and adolescents between the ages of 2 and 18 2. Diagnosed with generalized or focal epilepsy and experiencing seizures that remain uncontrolled despite treatment with two or more anticonvulsant medications.

Exclusion criteria

Exclusion criteria: 1. Children under 2 years old or adults over 18 years old. 2. Suffer from a respiratory tract infection or have a nasal allergy. 3. Have previously undergone surgery on the nose. 4. Have a history of allergic reactions to essential oils.

Design outcomes

Primary

MeasureTime frame
Number and duration of seizures within 1 month after end of the intervention Electroencephalogram (EEG)

Secondary

MeasureTime frame
Quality of life within 1 month after end of the intervention Pediatric Quality of Life Inventory (PedsQL)

Countries

Thailand

Contacts

Public ContactPhattranit Neelputtiphat

Phramongkutklao College of Medicine

std6548071@pcm.ac.th0634194939

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026